Join

Compare · LMDX vs VRAX

LMDX vs VRAX

Side-by-side comparison of LumiraDx Limited (LMDX) and Virax Biolabs Group Limited (VRAX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both LMDX and VRAX operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
  • LMDX carries a market cap of $2.23B.
  • VRAX has hit the wire 3 times in the past 4 weeks while LMDX has been quiet.
  • LMDX has more recent analyst coverage (4 ratings vs 1 for VRAX).
MetricLMDXVRAX
Company
LumiraDx Limited
Virax Biolabs Group Limited
Price
$0.02-53.80%
$0.16+0.50%
Market cap
$2.23B
-
1M return
-
-13.45%
1Y return
-
-83.38%
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Exchange
NASDAQ
NASDAQ
IPO
2022
News (4w)
0
3
Recent ratings
4
1
VRAX

Virax Biolabs Group Limited

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company offers rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, and individual consumers. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. The company was incorporated in 2021 and is based in London, the United Kingdom.